From eczema and psoriasis to arthritis and Parkinson’s, the appearance of our hands can tell us a lot about the state of our ...

That’s why we’ve rounded up home products that reviewers with arthritis vouch for to make life easier and more comfortable — ...

Across 2024, top immunology news focused on ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis, ...

A greater percentage of patients with PsA who received deucravacitinib vs placebo achieved minimal disease activity at 16 weeks.

Adult clinical trials found that Tremfya could treat plaque psoriasis by 16 weeks. Follow-up analysis found that roughly 23% ...

A study identifies clinical characteristics and predictors of psoriatic arthritis in patients with juvenile idiopathic ...

Delayed diagnosis is a widely recognised problem in psoriatic arthritis (PsA) and is directly related to poorer functional ...

According to study results published in RMD Open, patients with psoriatic arthritis (PsA) face a substantial risk for chronic kidney disease (CKD). Key risk factors contributing include diabetes, ...

Long-term treatment with guselkumab is associated with sustained improvements in joint/skin symptoms and disease activity among patients with active PsA.

The Waterloo Road actor has been nothing but open and honest about his struggles with arthritis since his diagnosis last year ...

A study of rheumatoid and psoriatic arthritis patients has found some experience a significant degree of relief with ...

The latest DWP data confirmed that there are now 3.6m people in Britain claiming PIP, which is worth up to £737 every month if you meet the criteria.